ABVC
ABVC BioPharma, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.96
−3.99%Margins
Gross margin
100.0%
EBITDA margin
983.2%
EBIT margin
918.6%
Net margin
992.8%
FCF margin
307.4%
-76.8%
Return on equity
-40.7%
Return on assets
-60.7%
Return on invested capital
-0.04x
Asset turnover
-$2.7M
Cash from operations
$0.00
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026